 AUSTIN, Texas, June 4, 2021 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA cfDNA testing, today announced it will present new data on its latest scientific innovations in cfDNA testing at the American Transplant Congress ATC 2021 Virtual Connect, taking place June 4-9, 2021. Three posters showcasing the scientific progress and performance of the Prospera test will be presented along with four sponsored presentations featuring leading transplant physicians. 